Screening for Latent Tuberculosis in Children With Immune-mediated Inflammatory Diseases Treated With Anti-tumor Necrosis Factor Therapy: Comparison of Tuberculin Skin and T-SPOT Tuberculosis Tests
Gİrİt S, Ayzit Atabek A, Şenol E, KoÇkar Kizilirmak T, Pekcan S, GÖktaŞ Ş, Öktem S, KasapÇopur Ö, ÇokuĞraŞ H. Screening for Latent Tuberculosis in Children With Immune-mediated Inflammatory Diseases Treated With Anti-tumor Necrosis Factor Therapy: Comparison of Tuberculin Skin and T-SPOT Tuberculosis Tests. Archives Of Rheumatology 2020, 35: 020-028. PMID: 32637916, PMCID: PMC7322294, DOI: 10.5606/archrheumatol.2020.7294.Peer-Reviewed Original ResearchTuberculin skin testLatent tuberculosis infectionValues of TSTSixth monthT-SPOTSkin testInflammatory diseasesTuberculosis testAnti-tumor necrosis factor therapyAnti-tumor necrosis factor treatmentNecrosis factor therapyAnti-TNF agentsAnti-TNF therapyProspective multicentric studyNecrosis factor treatmentFactor therapyLatent tuberculosisTuberculin skinTuberculosis infectionMulticentric studyLocal guidelinesTB testFactor treatmentPatientsMonths